Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury

References

• Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet 1985;2:125–7.
   PubMed Web of Science ®Google Scholar
• Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell KD. Continuous infusion of intrathecal baclofen. Long-term effects on spasticity in spinal cord injury. Paraplegia 1991;29:48–64.
   Google Scholar
• Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. American Journal of Physical Medicine and Rehabilitation 1992;71:321–7.
   Google Scholar
• Penn RD. Intrathecal baclofen for spasticity of spinal origin. Seven years of experience. Journal of Neurosurgery 1992;77:236–40.
   Web of Science ®Google Scholar
• Lazorthes Y, Sallerin-Caute B, Verdie JC, Verdie JC, Bastide R, Carrillo JP. Chronic intrathecal baclofen administration for control of severe spasticity. Journal of Neurosurgery 1990;72:393–402.
   PubMed Web of Science ®Google Scholar
• Hugenholtz H, Nelson RF, Dehoux E, Bickerton R. Intrathecal baclofen for intractable spinal spasticity-a double-blind cross-over comparison with placebo in 6 patients. Canadian Journal of Neurological Sciences 1992;19:188–95.
   PubMed Web of Science ®Google Scholar
• Coffey JR, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, Herman R, Shetter AG, Levy R, Gill B. Intrathecal baclofen for intractable spasticity of spinal origin. Results of a long-term multicenter study. Journal of Neurosurgery 1993;78:226–32.
   PubMed Web of Science ®Google Scholar
• Abel NA, Smith RA. Intrathecal baclofen for treatment of intractable spinal spasticity. Archives of Physical Medicine and Rehabilitation 1994;75:54–8.
   PubMed Web of Science ®Google Scholar
• Nance P, Schryvers O, Schmidt B, Dubo H, Overidge B, Fewer D. Intrathecal baclofen therapy for adults with spinal spasticity. Therapeutic efficacy and effect on hospital admis-sions. Canadian Journal of Neurological Sciences 1995;22:22–9.
   PubMed Web of Science ®Google Scholar
• Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity. Functional improvement and long-term follow-up. Archives of Physical Medicine and Rehabilitation 1996;77:35–9.
   Google Scholar
• Ordia JI, Fischer E, Adamski E, Spatz EL. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. Journal of Neurosurgery 1996;85:452–7.
   PubMed Web of Science ®Google Scholar
• Middel B, Kuipers-Upmeijer H, Bouma J, Staal M, Oenema D, Postma T, Terpstra S, Stewart R. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. Journal of Neurology, Neurosurgery, and Psychiatry 1997;63:204–9.
   PubMed Web of Science ®Google Scholar
• Burns AS, Meythaler JM. Intrathecal baclofen in tetraplegia of spinal origin. Efficacy for upper extremity hypertonia. Spinal Cord 2001;39:413–9.
   PubMed Web of Science ®Google Scholar
• Korenkov Al, Niendorf WR, Darwish N, Glaeser E, Gaab MR Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries. Neurosurgical Review 2002;25:228–30.
   PubMed Web of Science ®Google Scholar
• Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity: A clinical survey. American Journal of Physical Medicine and Rehabilitation 2000;79:536–41.
   PubMed Web of Science ®Google Scholar
• Saltuari L, Schmutzhard E, Kofler M, Baumgartner H, Aichner F, Gestenbrand F. Intrathecal baclofen for intractable spasticity due to severe brain injury. Lancet 1989;2:503–4.
   PubMed Web of Science ®Google Scholar
• Meythaler JM, Guin-Renfroe S, Grabb P, et al. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Archives of Physical Medicine and Rehabilitation 1999;80:13–9.
   PubMed Web of Science ®Google Scholar
• Rffici C, Kofler M, Kronenberg M, Kofler A, Bramanti P, Saltuari L. Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury. Functional Neurology 1994;9:29–34.
   PubMedGoogle Scholar
• Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991;265:1418–22.
   Google Scholar
• Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN. Intrathecal baclofen for spastic hypertonia from stroke. Stroke 2001;32:2099–9.
   PubMed Web of Science ®Google Scholar
• Becker R, Alberti O, Bauer BL. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. Journal of Neurology 1997; 244:160–6.
   Google Scholar
• Francisco GE, Boake C. Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: A preliminary study. Archives of Physical Medicine and Rehabilitation 2003;84:194–9.
   Web of Science ®Google Scholar
• Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle and Nerve Supplement 1997;6:592–120.
   Google Scholar
• Brailowsky S, Knight RT, Blood K, Scabini D. Gamma-Aminobutyric acid-induced potentiation of cortical hemiple-gia. Brain Research 1986;362:322–30.
   PubMed Web of Science ®Google Scholar
• Schallert T, Hernandez TD, Barth, TM. Recovery of function after brain damage: Severe and chronic disruption by diazepam. Brain Research 1986;379:104–11.
   PubMed Web of Science ®Google Scholar
• Francois B, Vacher P, Roustan J, Salle JY, Vidal J, Moreau JJ, Vignon P. Intrathecal baclofen after traumatic brain injury: Early treatment using a new technique to prevent spasticity. Journal of Trauma 2001;50:158–61.
   Google Scholar
• Cuny E, Richer E, Castel JP. Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: Relief with intrathecal baclofen therapy. Brain Injury 2001;15:917–25.
   Google Scholar
• Rawicki B. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: Long-term follow-up review of 18 patients. Journal of Neurosurgery 1999;91:733–6.
   PubMed Web of Science ®Google Scholar
• Becker R, Benes L, Sure U, Hellwig D, Bertalanfly H. Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury. Journal of Clinical Neuroscience 2000;7:316–9.
   Google Scholar
• Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy 1987;67:206–7.
   PubMed Web of Science ®Google Scholar
• Rappaport M, Hall KM, Hopkins K, Belleza J, Cope DN. Disability Rating Scale for severe head trauma: Coma to community. Archives of Physical Medicine and Rehabilitation 1982;63:118–23.
   Google Scholar
• Zar JH. Biostatistical analysis. Englewood Cliffs, NJ: Prentice-Hall; 1984.
   Google Scholar
• Goldstein LB, Matchar DB, Morgenlander JC, Davis JN. Influence of drugs on the recovery of sensorimotor function after stroke. Journal of Neurologic Rehabilitation 1990;4: 137–44.
   Google Scholar
• Goldstein LB. Common drugs may influence motor recovery after stroke. The Sygen in acute stroke study investigators. Neurology 1995;45:865–71.
   Google Scholar